Novavax, a pharmaceutical firm that created a Covid vaccine, has agreed to resolve a Class Action lawsuit and establish a $47,000,000 fund to pay back ...
Novavax's updated protein-based non-mRNA COVID-19 vaccine will be available in Canada for individuals aged 12 and older in the coming ...
Updated Sarah BranerThe premier global health authority has given Novavax’s updated COVID-19 shot a stamp of approval.The ...
Novavax (NASDAQ:NVAX) has agreed to settle a securities class action over its COVID-19 vaccine claims for $47M. The lawsuit was filed in 2021 by Sothinathan Sinnathurai in the U.S. District Court of ...
Listen to this article Gaithersburg-based Novavax Inc. Tuesday announced its Nuvaxovid XBB.1.5 COVID-19 vaccine (NVX-CoV2601) ...
Novavax has been granted emergency use listing (EUL) by the World Health Organisation (WHO) for its updated form of the ...
Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced ...
FDA Authorizes Updated Novavax COVID-19 Vaccine Formulated to Better Protect Against Currently Circulating Variants - ...
Health Canada has authorized an adapted vaccine from Novavax to prevent COVID-19 in people age 12 and older.The vaccine uses ...
In this radio interview with John Batchelor, our conversation includes (1) the approval of the latest COVID vaccines; and (2) ...
Past doses of the COVID vaccine will not protect you against the current strains. Current available vaccines include ...
As with vaccines for other illnesses, the Center for Disease Control (CDC) highly recommends anyone over the age of five ...
